109 related articles for article (PubMed ID: 24623743)
1. Differential roles of PPARĪ³ vs TR4 in prostate cancer and metabolic diseases.
Liu S; Lin SJ; Li G; Kim E; Chen YT; Yang DR; Tan MH; Yong EL; Chang C
Endocr Relat Cancer; 2014 Jun; 21(3):R279-300. PubMed ID: 24623743
[TBL] [Abstract][Full Text] [Related]
2. TR2 and TR4 Orphan Nuclear Receptors: An Overview.
Lin SJ; Yang DR; Yang G; Lin CY; Chang HC; Li G; Chang C
Curr Top Dev Biol; 2017; 125():357-373. PubMed ID: 28527578
[TBL] [Abstract][Full Text] [Related]
3. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C
Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinediones/PPARĪ³ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
[TBL] [Abstract][Full Text] [Related]
5. TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.
Lin SJ; Yang DR; Li G; Chang C
Front Endocrinol (Lausanne); 2015; 6():78. PubMed ID: 26074876
[TBL] [Abstract][Full Text] [Related]
6. Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4.
Lin SJ; Zhang Y; Liu NC; Yang DR; Li G; Chang C
Mol Endocrinol; 2014 Jun; 28(6):805-21. PubMed ID: 24702179
[TBL] [Abstract][Full Text] [Related]
7. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.
Lin SJ; Lee SO; Lee YF; Miyamoto H; Yang DR; Li G; Chang C
Carcinogenesis; 2014 Jun; 35(6):1399-406. PubMed ID: 24583925
[TBL] [Abstract][Full Text] [Related]
8. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C
Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291
[TBL] [Abstract][Full Text] [Related]
9. TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.
Lin SJ; Yang DR; Wang N; Jiang M; Miyamoto H; Li G; Chang C
Oncoscience; 2015; 2(2):142-50. PubMed ID: 25859557
[TBL] [Abstract][Full Text] [Related]
10. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
11. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
[TBL] [Abstract][Full Text] [Related]
12. Human testicular orphan receptor 4 enhances thyroid hormone receptor signaling.
Huang YH; Liao CH; Chen RN; Liao CJ; Lin KH
J Cell Physiol; 2010 Feb; 222(2):347-56. PubMed ID: 19859911
[TBL] [Abstract][Full Text] [Related]
13. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS
Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570
[TBL] [Abstract][Full Text] [Related]
14. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
Subbarayan V; Krieg P; Hsi LC; Kim J; Yang P; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
Oncogene; 2006 Sep; 25(44):6015-25. PubMed ID: 16682954
[TBL] [Abstract][Full Text] [Related]
15. Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells.
Xu Y; Iyengar S; Roberts RL; Shappell SB; Peehl DM
J Cell Physiol; 2003 Jul; 196(1):131-43. PubMed ID: 12767049
[TBL] [Abstract][Full Text] [Related]
16. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C
Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427
[TBL] [Abstract][Full Text] [Related]
17. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma in human prostate carcinoma.
Nakamura Y; Suzuki T; Sugawara A; Arai Y; Sasano H
Pathol Int; 2009 May; 59(5):288-93. PubMed ID: 19432669
[TBL] [Abstract][Full Text] [Related]
19. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals.
Bai J; Yeh S; Qiu X; Hu L; Zeng J; Cai Y; Zuo L; Li G; Yang G; Chang C
Oncogene; 2018 Nov; 37(44):5901-5912. PubMed ID: 29973687
[TBL] [Abstract][Full Text] [Related]
20. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]